Editorial Comment on "Gynecologic Manifestations of Interstitial Cystitis/Bladder Pain Syndrome" by K. E. Whitmore and J. Pires.

OA: gold
AI-generated deep summary by claude@2026-07, 2026-07-03 · read from full text

This editorial comment provides a comprehensive review of gynecologic manifestations and comorbid symptoms within interstitial cystitis/bladder pain syndrome (BPS/IC), emphasizing that clear gynecologic causes of chronic pelvic pain should be ruled out as confusable diseases. It discusses endometriosis and vulvodynia/vulvar pain syndrome as potential comorbidities in BPS/IC patients, along with other conditions such as high tone pelvic floor dysfunction, pudendal neuralgia, and dyspareunia, noting that symptom disappearance during pregnancy is discussed as evidence for estrogen influence. The comment outlines diagnostic approaches for chronic pelvic pain, and describes a multimodal management approach that uses BPS/IC methods plus symptomatic gynecologic treatment, with psychological support stressed; it also states there is no cure for BPS/IC due to limited knowledge of causes. Relevance to endometriosis: the paper explicitly discusses endometriosis as a gynecologic comorbidity present in BPS/IC patients and frames its role among other pelvic pain conditions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,976 characters · extracted from pmc-nxml · 2 sections · click to expand

Coi Statement

The author declares no conflicts of interest.

Opening Section

This is a comprehensive review of what is known about BPS/IC gynecologic influences, related symptoms and signs. Following the actual guidelines clear gynecologic causes of Chronic Pelvic Pain are to be discarded from the BPS/IC Syndrome as confusable diseases [ 1 ]. On the contrary are gynecologic comorbidities present in a high number of BPS/IC patients where both syndromes are responsible for symptoms. Endometriosis, vulvodynia/vulvar pain syndrome are discussed. Other conditions as a high pelvic tone of the pelvic floor (high tone pelvic floor dysfunction HTPFD), pudendal neuralgia (PN) and dyspareunia form a mixed group that can occur with pathology of different pelvic structures and organs or on their own. The report in patients who have BPS/IC and see the symptoms disappear when they become pregnant point also to the important influence of estrogens. Diagnostic methods are given for CPP: These are extended but in experienced hands not too time consuming. Treatment will use methods developed for BPS/IC and add symptomatic treatment of gynecologic conditions. In principle treatment should start with conservative measures including rules of good behavior and self‐care. Ample importance should be given to psychological support. When these treatments fail to bring relieve, more invasive methods are available. It is important to discuss all with the patient beforehand, in detail. It is extremely important to present the possible results of the BPS/IC treatments: what can be promised and what not. There is no cure available for the BPS/IC condition today related to the absence of knowledge about causes. Trying to improve all symptoms should be the goal. This involves in many a multimodal treatment and involvement of different specialties. It remains a difficult but fascinating clinical entity for the physician and a devastating experience for the patient which needs attentive and supportive care.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

SciLite annotations

chemicals 1
estrone

Source provenance

europepmc
last seen: 2026-08-16T09:21:09.727480+00:00
scilite
last seen: 2026-07-19T09:54:07.271699+00:00
unpaywall
last seen: 2026-06-24T06:27:47.060558+00:00